Jazz Pharmaceuticals (JAZZ) Interest Coverage Ratio (2010 - 2013)
Jazz Pharmaceuticals (JAZZ) recorded quarterly Interest Coverage Ratio of 163.78 in Q3 2013, down 18.18% quarter-over-quarter from 200.17 in Q2 2013, and up 225.48% on a YoY basis from 50.32 in Q3 2012.
Jazz Pharmaceuticals (JAZZ) Interest Coverage Ratio (2010 - 2013) Analysis & Trends
Jazz Pharmaceuticals' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 163.78 for Q3 2013.
- In Q3 2013, Interest Coverage Ratio rose 225.48% year-over-year to 163.78; the TTM figure through Jun 2014 stood at 301.72 (up 291.44% YoY), while the FY2013 annual figure was 200.54, up 266.93% from the prior year.
- Interest Coverage Ratio was 163.78 for Q3 2013 at Jazz Pharmaceuticals, down from 200.17 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 200.17 in Q2 2013 to a low of 251.61 in Q1 2013.
- Historically, Interest Coverage Ratio has averaged 40.54 across 4 years, with a median of 41.5 in 2010.
- Biggest YoY gain for Interest Coverage Ratio was 225.48% in 2013; the steepest drop was 21.85% in 2013.
- A 4-year view of Interest Coverage Ratio shows it stood at 44.8 in 2010, then jumped by 214.69% to 51.38 in 2011, then sank by 42.05% to 29.77 in 2012, then jumped by 450.07% to 163.78 in 2013.
- The last three Interest Coverage Ratio figures came in at 163.78 (Q3 2013), 200.17 (Q2 2013), and 251.61 (Q1 2013), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Jazz Pharmaceuticals | 13.91 Bn | 12.06 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 163.78 |
| Jun 30, 2013 | 200.17 |
| Mar 31, 2013 | -251.61 |
| Dec 31, 2012 | 29.77 |
| Sep 30, 2012 | 50.32 |
| Jun 30, 2012 | 164.28 |
| Jun 30, 2011 | 51.38 |
| Mar 31, 2011 | 29.09 |
| Dec 31, 2010 | -44.80 |
| Sep 30, 2010 | 12.07 |
| Jun 30, 2010 | 41.50 |